147 related articles for article (PubMed ID: 30714683)
1. Role of postoperative radiotherapy in pT3N0 rectal cancer: A risk-stratification system based on population analyses.
Huang YX; Lin YZ; Li JL; Zhang XQ; Tang LR; Zhuang QY; Lin FF; Lin XJ; Wu JX
Cancer Med; 2019 Mar; 8(3):1024-1033. PubMed ID: 30714683
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
[TBL] [Abstract][Full Text] [Related]
3. Survival outcome of adjuvant radiotherapy after local excision for T2 early rectal cancer: An analysis based on the surveillance, epidemiology, and end result registry database.
Wang XJ; Chi P; Zhang YY; Lin HM; Lu XR; Huang Y; Xu ZB; Ghareeb WM; Huang SH; Sun YW; Ye DX
Eur J Surg Oncol; 2018 Dec; 44(12):1865-1872. PubMed ID: 30262325
[TBL] [Abstract][Full Text] [Related]
4. Surveillance, epidemiology, and end results-based analysis of the impact of preoperative or postoperative radiotherapy on survival outcomes for T3N0 rectal cancer.
Peng LC; Milsom J; Garrett K; Nandakumar G; Coplowitz S; Parashar B; Nori D; Clifford Chao KS; Wernicke AG
Cancer Epidemiol; 2014 Feb; 38(1):73-8. PubMed ID: 24491755
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant radiotherapy improves cause specific survival in stage II, not stage III mucinous carcinoma of the rectum.
Li Q; Li Y; Dai W; Wang S; Xu Y; Li X; Cai S
BMC Cancer; 2017 Jan; 17(1):80. PubMed ID: 28122523
[TBL] [Abstract][Full Text] [Related]
6. Tumor location as an indication for adjuvant radiotherapy in pT3N0 rectal cancer after surgery.
Peng HH; Zhou XH; Zhou TC; Qiu XS; You KY
Radiat Oncol; 2019 Jan; 14(1):8. PubMed ID: 30651116
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors of overall survival and cancer-specific survival in patients with resected early-stage rectal adenocarcinoma: a SEER-based study.
Lee KC; Chung KC; Chen HH; Liu CC; Lu CC
J Investig Med; 2017 Dec; 65(8):1148-1154. PubMed ID: 28735257
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant Chemotherapy Seemed Not to Have Survival Benefit in Rectal Cancer Patients with ypTis-2N0 After Preoperative Radiotherapy and Surgery from a Population-Based Propensity Score Analysis.
Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai SJ
Oncologist; 2019 Jun; 24(6):803-811. PubMed ID: 29674444
[TBL] [Abstract][Full Text] [Related]
9. Lymph node status after neoadjuvant radiotherapy for rectal cancer is a biologic predictor of outcome.
Chang GJ; Rodriguez-Bigas MA; Eng C; Skibber JM
Cancer; 2009 Dec; 115(23):5432-40. PubMed ID: 19673001
[TBL] [Abstract][Full Text] [Related]
10. Use of lymph node ratio to guide clinical decision-making concerning adjuvant radiotherapy in pT1-2N1 rectal cancer.
Luo D; Ye Z; Zhang R; Li Q; Li X
Int J Colorectal Dis; 2023 May; 38(1):115. PubMed ID: 37148381
[TBL] [Abstract][Full Text] [Related]
11. Preoperative radiotherapy improves survival in rectal signet-ring cell carcinoma-a population-based study.
Wu SG; Zhang WW; Sun JY; He ZY; Su GQ; Li FY
Radiat Oncol; 2017 Aug; 12(1):141. PubMed ID: 28835256
[TBL] [Abstract][Full Text] [Related]
12. Log odds of positive lymph nodes is a superior prognostic indicator in stage III rectal cancer patients: A retrospective analysis of 17,632 patients in the SEER database.
Huang B; Chen C; Ni M; Mo S; Cai G; Cai S
Int J Surg; 2016 Aug; 32():24-30. PubMed ID: 27321382
[TBL] [Abstract][Full Text] [Related]
13. Prognoses in Pathologically Confirmed T1 Lower Rectal Cancer Patients with or without Preoperative Therapy: An Analysis Using the Surveillance, Epidemiology, and End Results Database.
Taira T; Nozawa H; Kawai K; Sasaki K; Murono K; Emoto S; Kishikawa J; Ozawa T; Yokoyama Y; Abe S; Nagai Y; Anzai H; Sonoda H; Ishihara S
Oncology; 2022; 100(2):82-88. PubMed ID: 34818659
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy for Patients With Resected Tumor Deposit-Positive Colorectal Cancer: A Surveillance, Epidemiology, and End Results-Based Population Study.
Chavali LB; Llanos AAM; Yun JP; Hill SM; Tan XL; Zhang L
Arch Pathol Lab Med; 2018 Jun; 142(6):721-729. PubMed ID: 29048218
[TBL] [Abstract][Full Text] [Related]
15. Identification of a high-risk subgroup of patients with resected pT3 oral cavity cancer in need of postoperative adjuvant therapy.
Liao CT; Lin CY; Fan KH; Huang SF; Chen IH; Kang CJ; Wang HM; Ng SH; Hsueh C; Lee LY; Lin CH; Yen TC
Ann Surg Oncol; 2011 Sep; 18(9):2569-78. PubMed ID: 21360248
[TBL] [Abstract][Full Text] [Related]
16. Nomograms to predict survival and the risk for developing local or distant recurrence in patients with rectal cancer treated with optional short-term radiotherapy.
van Gijn W; van Stiphout RGPM; van de Velde CJH; Valentini V; Lammering G; Gambacorta MA; Påhlman L; Bujko K; Lambin P
Ann Oncol; 2015 May; 26(5):928-935. PubMed ID: 25609247
[TBL] [Abstract][Full Text] [Related]
17. LODDS is superior to lymph node ratio for the prognosis of node-positive rectal cancer patients treated with preoperative radiotherapy.
Huang B; Ni M; Chen C; Cai G; Cai S
Tumori; 2017 Jan; 103(1):87-92. PubMed ID: 27716883
[TBL] [Abstract][Full Text] [Related]
18. Predictors for regional lymph node metastasis in T1 rectal cancer: a population-based SEER analysis.
Brunner W; Widmann B; Marti L; Tarantino I; Schmied BM; Warschkow R
Surg Endosc; 2016 Oct; 30(10):4405-15. PubMed ID: 26895892
[TBL] [Abstract][Full Text] [Related]
19. Increased number of negative lymph nodes is associated with improved cancer specific survival in pathological IIIB and IIIC rectal cancer treated with preoperative radiotherapy.
Li Q; Zhuo C; Cai G; Li D; Liang L; Cai S
Oncotarget; 2014 Dec; 5(23):12459-71. PubMed ID: 25514596
[TBL] [Abstract][Full Text] [Related]
20. Survival outcome of operated and non-operated elderly patients with rectal cancer: A Surveillance, Epidemiology, and End Results analysis.
Bhangu A; Kiran RP; Audisio R; Tekkis P
Eur J Surg Oncol; 2014 Nov; 40(11):1510-6. PubMed ID: 24704032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
